Why Is TRULIEVE CANNABIS CO (TRLV) Stock Down Today?
By the Top Tier Newswire AI Desk · October 1, 2026 at 12:04 AM ET · reviewed against 5 wire stories
TRULIEVE CANNABIS CO (TRLV) is down -12.17% in the latest session. Our newswire has captured 5 stories on TRLV across 4 sources in the last 36 hours, with AI sentiment reading bearish (avg 41/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why TRLV stock is down today
Trulieve Cannabis Co. shares fell 12.17% to $10.90 in a session shaped by regulatory uncertainty. The decline followed a ruling by DEA Chief Judge Derek Julius, who paused the cannabis rescheduling case. This development has raised concerns about the long-term legal and commercial future for cannabis companies, including Trulieve.
What Happened
The stock’s sharp drop came after a judge delayed a decision on whether to reschedule cannabis under federal law. This pause introduces regulatory ambiguity that could affect the industry’s growth trajectory and access to capital. Cantor Fitzgerald maintained its existing stock rating for Trulieve despite the ruling, indicating that the firm sees no immediate change in its outlook for the company. Meanwhile, the broader market saw mixed movements in other sectors, with unrelated stocks like Conagra Brands and Concentrix also experiencing volatility.
What The Data Shows
Trulieve’s fundamentals remain challenging, with a trailing twelve-month revenue decline of 3.9% and a net margin of -41.6%. The stock has traded between $7.82 and $12.93 over the past 52 weeks and is currently near the lower end of that range. The company has printed 14 fresh 52-week lows on September 30, 2026, indicating a prolonged period of weakness. With a beta of 1.76, the stock is more volatile than the broader market, amplifying its response to external shocks like the DEA ruling.
What To Watch
Investors should monitor the rescheduling case for further developments, as any regulatory shift could significantly impact Trulieve’s business. The company’s next earnings report will also be a key event to assess its operational performance and financial resilience.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Cantor Fitzgerald reiterates Trulieve Cannabis stock rating after DEA pause
Cantor Fitzgerald reiterates Trulieve Cannabis stock rating after DEA pause
51d agoInvesting.com MarketsBEARISH 38General
Why is Trulieve Cannabis stock sliding today?
Why is Trulieve Cannabis stock sliding today?
51d agoStocktwits NewsBEARISH 38General
MSOS, TRLV Slide After Hours As DEA Judge Pauses Cannabis Rescheduling Case
DEA Chief Judge Derek Julius paused the cannabis rescheduling case on Tuesday afternoon.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →